Canuso CM - Search Results

1

Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone.

Canuso CM, Grinspan A, Kalali A, Damaraju CV, Merriman U, Alphs L, Awad AG. Canuso CM, et al. Int Clin Psychopharmacol. 2010 May;25(3):155-64. doi: 10.1097/YIC.0b013e3283372977. Int Clin Psychopharmacol. 2010. PMID: 20216424 Clinical Trial.

2

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder.

Hirschfeld RM, Eerdekens M, Kalali AH, Canuso CM, Khan AA, Karcher K, Palumbo JM. Hirschfeld RM, et al. Among authors: canuso cm. Int Clin Psychopharmacol. 2006 Jan;21(1):11-20. doi: 10.1097/01.yic.0000177017.41558.fc. Int Clin Psychopharmacol. 2006. PMID: 16317312 Clinical Trial.

3

Risperidone for treatment-refractory major depressive disorder: a randomized trial.

Mahmoud RA, Pandina GJ, Turkoz I, Kosik-Gonzalez C, Canuso CM, Kujawa MJ, Gharabawi-Garibaldi GM. Mahmoud RA, et al. Among authors: canuso cm. Ann Intern Med. 2007 Nov 6;147(9):593-602. doi: 10.7326/0003-4819-147-9-200711060-00003. Ann Intern Med. 2007. PMID: 17975181 Clinical Trial.

4

Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial.

Pandina GJ, Canuso CM, Turkoz I, Kujawa M, Mahmoud RA. Pandina GJ, et al. Among authors: canuso cm. Psychopharmacol Bull. 2007;40(3):41-57. Psychopharmacol Bull. 2007. PMID: 18007568 Clinical Trial.

5

Gender and schizophrenia.

Canuso CM, Pandina G. Canuso CM, et al. Psychopharmacol Bull. 2007;40(4):178-90. Psychopharmacol Bull. 2007. PMID: 18227787 Review.

6

Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.

Canuso CM, Youssef EA, Bossie CA, Turkoz I, Schreiner A, Simpson GM. Canuso CM, et al. Int Clin Psychopharmacol. 2008 Jul;23(4):209-15. doi: 10.1097/YIC.0b013e3282fce651. Int Clin Psychopharmacol. 2008. PMID: 18545059 Clinical Trial.

7

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia.

Turkoz I, Bossie CA, Dirks B, Canuso CM. Turkoz I, et al. Among authors: canuso cm. Neuropsychiatr Dis Treat. 2008 Oct;4(5):949-58. doi: 10.2147/ndt.s3668. Neuropsychiatr Dis Treat. 2008. PMID: 19183785 Free PMC article.

8

Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia.

Canuso CM, Dirks B, Carothers J, Kosik-Gonzalez C, Bossie CA, Zhu Y, Damaraju CV, Kalali AH, Mahmoud R. Canuso CM, et al. Am J Psychiatry. 2009 Jun;166(6):691-701. doi: 10.1176/appi.ajp.2009.08040613. Epub 2009 May 1. Am J Psychiatry. 2009. PMID: 19411369 Clinical Trial.

9

Efficacy and safety of paliperidone extended-release in schizophrenia patients with prominent affective symptoms.

Canuso CM, Turkoz I, Sheehan JJ, Bossie CA. Canuso CM, et al. J Affect Disord. 2010 Jan;120(1-3):193-9. doi: 10.1016/j.jad.2009.05.025. J Affect Disord. 2010. PMID: 19552963 Clinical Trial.

10

Paliperidone extended-release for schizophrenia: effects on symptoms and functioning in acutely ill patients with negative symptoms.

Canuso CM, Bossie CA, Turkoz I, Alphs L. Canuso CM, et al. Schizophr Res. 2009 Aug;113(1):56-64. doi: 10.1016/j.schres.2009.05.021. Epub 2009 Jun 26. Schizophr Res. 2009. PMID: 19560322 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters